Dominacja leków generycznych na rynku farmaceutycznym Europy Środkowo-Wschodniej będzie kontynuowana - listopad 2009

Rynek farmaceutyczny Europy Środkowo-Wschodnie zdominowany jest przez leki generyczne. Ten segment był wart w 2008 r. 17,2 mld euro, a w latach 2009-2011 będzie rozwijał się w tempie około 14% rocznie. Tempo wzrostu leków innowacyjnych, których rynek był wart 12,4 mld zł w 2008 r. będzie niższe, wynika z najnowszego raportu firmy badawczej PMR pt. „Generic and innovative drugs market in Central and Eastern Europe 2009. Comparative analysis, reimbursement policies and development forecasts for 2009-2011”.

To open the FULL free article/document, please sign up.

*required


*Email:
		To make sure you receive the requested information, add info@pmrcorporate.com to your company trusted emails. Contact your IT department for details.
*Your company core business:
Help us better answer your needs. Why do you sign up?		Please specify:
		Privacy Policy

Free e-letters

PMR Publications provides market intelligence for business professionals interested in Central and Eastern European countries as well as other emerging markets. Publications by PMR analyse the business climate in the region. The offer includes both free and paid subscription newsletters, online news & analysis services and in-depth reports on Central and Eastern Europe. PMR Publications is a division of PMR, a British-American company providing market research (through PMR Research), consultancy (through PMR Consulting) and business publications (through PMR Publications).